Dual Trials Accelerate VELDONA® Toward Rare Disease Market EntryBridging Strategy Aims to Fast-Track U.S. Regulatory Approvals SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos, Inc. (N ...

Approval of Lynozyfic is based on data showing deep and durable responses in relapsed/refractory multiple myeloma Lynozyfic will provide a new option with convenient dosing and administration to patie ...

The study's primary endpoint is overall survival (OS) and the secondary endpoints include progression-free survival (PFS), objective response rate (ORR) and disease control rate (DCR). The ...

The study results show that hOMSC200 is safe and did not elicit any immune response ... The primary end point was safety, including treatment-related adverse events and immunological rejection ...

Discover a study where researchers identified a marked decline in monocyte function and maturation during the ...

The arm you offer up for vaccination could impact your immediate immune response. But here's the catch: scientists still aren ...

Another important area is protective immunity and memory T cell response. While antibody production following vaccination typically lasts about six months, what's more crucial is whether the vaccine ...

The publication explains ... New Phase of the Immune Response Uncovered Apr. 10, 2025 — A team has identified a previously unknown phase of the immune response. The results challenge long ...

The findings cast doubt on the current view that a lack of nutrients alone controls how the immune system responds to fasting, indicating the brain has a critical role, beyond the simple absence ...